| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polysaccharides, Bacterial | 157 | 2021 | 582 | 11.590 |
Why?
|
| Bacteroides fragilis | 93 | 2024 | 250 | 9.160 |
Why?
|
| Streptococcus agalactiae | 124 | 2019 | 337 | 7.820 |
Why?
|
| Bacterial Vaccines | 44 | 2019 | 400 | 3.790 |
Why?
|
| Francisella tularensis | 10 | 2019 | 60 | 3.600 |
Why?
|
| Streptococcal Infections | 58 | 2019 | 619 | 3.470 |
Why?
|
| Bacterial Capsules | 40 | 2019 | 247 | 3.320 |
Why?
|
| Intestines | 20 | 2020 | 1911 | 3.160 |
Why?
|
| Symbiosis | 21 | 2021 | 297 | 3.150 |
Why?
|
| Vaccines, Conjugate | 27 | 2019 | 334 | 3.000 |
Why?
|
| Streptococcal Vaccines | 14 | 2019 | 46 | 2.710 |
Why?
|
| Bacteroides Infections | 38 | 2012 | 89 | 2.670 |
Why?
|
| Antigens, Bacterial | 66 | 2019 | 1150 | 2.530 |
Why?
|
| Antibodies, Bacterial | 82 | 2019 | 1478 | 2.340 |
Why?
|
| Glycoconjugates | 5 | 2019 | 88 | 1.970 |
Why?
|
| Bacteria | 18 | 2023 | 2219 | 1.820 |
Why?
|
| Immune System | 10 | 2023 | 800 | 1.650 |
Why?
|
| O Antigens | 6 | 2019 | 196 | 1.590 |
Why?
|
| Gastrointestinal Tract | 6 | 2021 | 839 | 1.470 |
Why?
|
| Immunity, Maternally-Acquired | 14 | 2020 | 112 | 1.440 |
Why?
|
| Tularemia | 5 | 2019 | 40 | 1.420 |
Why?
|
| Adaptive Immunity | 7 | 2018 | 733 | 1.300 |
Why?
|
| Intestinal Mucosa | 16 | 2024 | 3047 | 1.250 |
Why?
|
| T-Lymphocytes | 36 | 2023 | 10276 | 1.210 |
Why?
|
| Toll-Like Receptor 2 | 12 | 2019 | 348 | 1.190 |
Why?
|
| Abscess | 29 | 2010 | 606 | 1.180 |
Why?
|
| Lipopolysaccharides | 23 | 2017 | 2222 | 1.160 |
Why?
|
| Carbohydrates | 9 | 2013 | 389 | 1.150 |
Why?
|
| Tetanus Toxoid | 18 | 2004 | 189 | 1.130 |
Why?
|
| Colitis | 6 | 2024 | 1244 | 1.050 |
Why?
|
| Animals | 214 | 2024 | 169408 | 1.040 |
Why?
|
| Complement C3 | 7 | 2024 | 434 | 1.010 |
Why?
|
| Mice | 122 | 2024 | 82074 | 0.980 |
Why?
|
| Glycoside Hydrolases | 6 | 2013 | 135 | 0.960 |
Why?
|
| Metagenome | 3 | 2013 | 465 | 0.890 |
Why?
|
| Immunity, Innate | 11 | 2023 | 3080 | 0.890 |
Why?
|
| CD4-Positive T-Lymphocytes | 17 | 2023 | 4413 | 0.820 |
Why?
|
| Antigens, Surface | 13 | 2019 | 1616 | 0.820 |
Why?
|
| Antigen Presentation | 8 | 2013 | 1252 | 0.810 |
Why?
|
| Polysaccharides | 11 | 2020 | 1024 | 0.800 |
Why?
|
| Histocompatibility Antigens Class II | 8 | 2011 | 1439 | 0.800 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 3 | 2020 | 151 | 0.790 |
Why?
|
| Clostridium | 4 | 2017 | 100 | 0.760 |
Why?
|
| Galactosylceramides | 1 | 2021 | 90 | 0.760 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2021 | 268 | 0.750 |
Why?
|
| Virulence Factors | 3 | 2019 | 502 | 0.750 |
Why?
|
| Carbohydrate Sequence | 33 | 2005 | 411 | 0.740 |
Why?
|
| Prevotella | 1 | 2020 | 81 | 0.720 |
Why?
|
| Lymphocytes | 5 | 2017 | 2614 | 0.720 |
Why?
|
| Bacteria, Anaerobic | 2 | 2017 | 71 | 0.690 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2020 | 32 | 0.680 |
Why?
|
| Antigen-Presenting Cells | 9 | 2011 | 962 | 0.670 |
Why?
|
| Vaccines | 3 | 2022 | 842 | 0.670 |
Why?
|
| Abdominal Abscess | 9 | 2003 | 153 | 0.670 |
Why?
|
| Germ-Free Life | 10 | 2023 | 187 | 0.670 |
Why?
|
| Bacteroides | 12 | 2010 | 165 | 0.650 |
Why?
|
| Immunity, Mucosal | 6 | 2023 | 498 | 0.640 |
Why?
|
| Bile Acids and Salts | 2 | 2024 | 400 | 0.610 |
Why?
|
| Salmonella Infections | 3 | 2017 | 172 | 0.610 |
Why?
|
| Natural Killer T-Cells | 4 | 2021 | 318 | 0.610 |
Why?
|
| Mice, Inbred C57BL | 43 | 2024 | 22381 | 0.600 |
Why?
|
| Antibody Formation | 17 | 2018 | 1393 | 0.590 |
Why?
|
| Bacterial Toxins | 10 | 2004 | 921 | 0.580 |
Why?
|
| Homeostasis | 6 | 2023 | 3348 | 0.570 |
Why?
|
| Vaccines, Attenuated | 5 | 2011 | 313 | 0.570 |
Why?
|
| Fungi | 1 | 2020 | 345 | 0.570 |
Why?
|
| Lymphocyte Subsets | 2 | 2017 | 313 | 0.570 |
Why?
|
| Peptidoglycan | 5 | 2017 | 246 | 0.560 |
Why?
|
| Immunity, Cellular | 12 | 2008 | 1560 | 0.560 |
Why?
|
| Immunoglobulin G | 30 | 2020 | 4568 | 0.550 |
Why?
|
| Epitopes | 28 | 2018 | 2529 | 0.540 |
Why?
|
| Dietary Fiber | 1 | 2020 | 767 | 0.540 |
Why?
|
| Citrobacter rodentium | 1 | 2016 | 64 | 0.540 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 5 | 2021 | 822 | 0.530 |
Why?
|
| Fatty Acids | 5 | 2023 | 1812 | 0.530 |
Why?
|
| Macrophages | 10 | 2017 | 5800 | 0.530 |
Why?
|
| Sphingolipids | 2 | 2024 | 178 | 0.520 |
Why?
|
| Dendritic Cells | 8 | 2020 | 2748 | 0.520 |
Why?
|
| Colon | 8 | 2023 | 1804 | 0.510 |
Why?
|
| Escherichia coli Infections | 1 | 2020 | 524 | 0.510 |
Why?
|
| Bacterial Proteins | 24 | 2010 | 3839 | 0.490 |
Why?
|
| Mice, Inbred BALB C | 16 | 2020 | 6232 | 0.490 |
Why?
|
| Milk, Human | 1 | 2020 | 490 | 0.490 |
Why?
|
| Enterobacteriaceae Infections | 2 | 2016 | 190 | 0.480 |
Why?
|
| T-Lymphocytes, Regulatory | 6 | 2020 | 3116 | 0.470 |
Why?
|
| Virus Diseases | 1 | 2020 | 724 | 0.470 |
Why?
|
| HLA-DR Antigens | 3 | 2008 | 609 | 0.460 |
Why?
|
| Lymphocyte Activation | 16 | 2013 | 5505 | 0.460 |
Why?
|
| Cell Membrane | 13 | 2020 | 3659 | 0.460 |
Why?
|
| Infant, Newborn, Diseases | 7 | 2013 | 587 | 0.460 |
Why?
|
| Bacterial Infections | 7 | 2013 | 1397 | 0.460 |
Why?
|
| Lymphoid Tissue | 2 | 2013 | 446 | 0.460 |
Why?
|
| Phagocytosis | 27 | 2005 | 1530 | 0.450 |
Why?
|
| Francisella | 1 | 2013 | 6 | 0.440 |
Why?
|
| Molecular Sequence Data | 41 | 2010 | 17629 | 0.440 |
Why?
|
| Immunomodulation | 4 | 2021 | 549 | 0.440 |
Why?
|
| Reactive Nitrogen Species | 2 | 2010 | 35 | 0.440 |
Why?
|
| Interleukin-10 | 6 | 2017 | 1184 | 0.440 |
Why?
|
| Glycosphingolipids | 1 | 2014 | 73 | 0.440 |
Why?
|
| Antibodies | 6 | 2020 | 2422 | 0.440 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2013 | 30 | 0.430 |
Why?
|
| Streptococcus pneumoniae | 15 | 2009 | 764 | 0.430 |
Why?
|
| Deoxycholic Acid | 2 | 2024 | 54 | 0.430 |
Why?
|
| Carbohydrate Conformation | 24 | 2003 | 206 | 0.420 |
Why?
|
| Tetanus Toxin | 1 | 2012 | 46 | 0.420 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2017 | 354 | 0.420 |
Why?
|
| Immune Evasion | 2 | 2014 | 376 | 0.410 |
Why?
|
| Bacterial Outer Membrane Proteins | 4 | 2007 | 404 | 0.400 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2018 | 977 | 0.400 |
Why?
|
| Interleukin-17 | 6 | 2017 | 925 | 0.400 |
Why?
|
| Salmonella typhimurium | 2 | 2017 | 348 | 0.390 |
Why?
|
| Immunization | 22 | 2011 | 1219 | 0.390 |
Why?
|
| Vaccines, Synthetic | 6 | 2000 | 622 | 0.380 |
Why?
|
| Virulence | 25 | 2007 | 1298 | 0.370 |
Why?
|
| Rabbits | 41 | 2002 | 4774 | 0.370 |
Why?
|
| Ovalbumin | 1 | 2012 | 677 | 0.360 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2010 | 260 | 0.360 |
Why?
|
| Sugar Acids | 1 | 2010 | 24 | 0.360 |
Why?
|
| Inflammatory Bowel Diseases | 6 | 2016 | 2445 | 0.360 |
Why?
|
| Proteome | 1 | 2020 | 1891 | 0.350 |
Why?
|
| Clindamycin | 6 | 2004 | 138 | 0.350 |
Why?
|
| Oligosaccharides | 8 | 2010 | 407 | 0.350 |
Why?
|
| Hexosyltransferases | 1 | 2010 | 58 | 0.350 |
Why?
|
| Legionella pneumophila | 1 | 2010 | 50 | 0.350 |
Why?
|
| Toll-Like Receptor 4 | 6 | 2020 | 587 | 0.350 |
Why?
|
| Chromosome Mapping | 4 | 2016 | 4624 | 0.340 |
Why?
|
| Water | 2 | 2011 | 1421 | 0.340 |
Why?
|
| Humans | 181 | 2024 | 768887 | 0.330 |
Why?
|
| Streptococcus | 5 | 2008 | 198 | 0.330 |
Why?
|
| Opsonin Proteins | 17 | 2005 | 144 | 0.330 |
Why?
|
| Enterotoxins | 3 | 1996 | 365 | 0.320 |
Why?
|
| Mice, Knockout | 20 | 2017 | 14485 | 0.320 |
Why?
|
| Vaccination | 16 | 2022 | 3436 | 0.320 |
Why?
|
| Helicobacter hepaticus | 1 | 2008 | 25 | 0.310 |
Why?
|
| Antigens, CD1d | 3 | 2021 | 225 | 0.310 |
Why?
|
| Models, Animal | 3 | 2021 | 2123 | 0.300 |
Why?
|
| Sialic Acids | 12 | 1996 | 123 | 0.300 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2016 | 1813 | 0.300 |
Why?
|
| Cross Reactions | 11 | 2020 | 828 | 0.300 |
Why?
|
| Immune Sera | 18 | 2003 | 605 | 0.300 |
Why?
|
| Neisseria meningitidis | 9 | 2018 | 111 | 0.300 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2011 | 827 | 0.290 |
Why?
|
| Cell Separation | 2 | 2012 | 1728 | 0.290 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 2133 | 0.290 |
Why?
|
| Infant, Newborn | 25 | 2020 | 26394 | 0.290 |
Why?
|
| Streptococcus pyogenes | 3 | 2007 | 293 | 0.280 |
Why?
|
| Animals, Newborn | 14 | 2014 | 2695 | 0.280 |
Why?
|
| Carbohydrate Metabolism | 1 | 2008 | 262 | 0.280 |
Why?
|
| Immunoglobulin A | 8 | 2020 | 992 | 0.280 |
Why?
|
| Disease Models, Animal | 28 | 2024 | 18366 | 0.280 |
Why?
|
| Helicobacter pylori | 1 | 2010 | 380 | 0.280 |
Why?
|
| Reactive Oxygen Species | 3 | 2010 | 2149 | 0.280 |
Why?
|
| Genes, Bacterial | 9 | 2009 | 1076 | 0.270 |
Why?
|
| Enterocytes | 2 | 2019 | 219 | 0.270 |
Why?
|
| Serotyping | 13 | 2005 | 332 | 0.270 |
Why?
|
| Disease Susceptibility | 6 | 2021 | 1794 | 0.270 |
Why?
|
| Immunity | 2 | 2020 | 1003 | 0.270 |
Why?
|
| Immunization, Passive | 11 | 1999 | 619 | 0.270 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2008 | 289 | 0.260 |
Why?
|
| Superantigens | 3 | 1996 | 124 | 0.260 |
Why?
|
| N-Acetylneuraminic Acid | 5 | 2018 | 175 | 0.260 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 19 | 2010 | 3814 | 0.260 |
Why?
|
| Androgens | 1 | 2013 | 1285 | 0.260 |
Why?
|
| Adoptive Transfer | 3 | 2014 | 824 | 0.250 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2005 | 88 | 0.250 |
Why?
|
| Autoimmunity | 1 | 2013 | 1360 | 0.250 |
Why?
|
| Rats | 35 | 2012 | 23847 | 0.250 |
Why?
|
| Host-Pathogen Interactions | 5 | 2017 | 1469 | 0.240 |
Why?
|
| Molecular Weight | 14 | 2003 | 2173 | 0.240 |
Why?
|
| Carrier Proteins | 7 | 2020 | 4940 | 0.240 |
Why?
|
| Interleukins | 2 | 2024 | 796 | 0.240 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2004 | 264 | 0.230 |
Why?
|
| Glycolipids | 2 | 2020 | 205 | 0.230 |
Why?
|
| Sepsis | 11 | 2005 | 2609 | 0.230 |
Why?
|
| Immunoglobulin M | 9 | 2008 | 1528 | 0.220 |
Why?
|
| Myeloid Differentiation Factor 88 | 5 | 2013 | 582 | 0.220 |
Why?
|
| Bacterial Load | 2 | 2016 | 154 | 0.220 |
Why?
|
| Peritoneal Diseases | 4 | 1990 | 76 | 0.220 |
Why?
|
| Isomerism | 1 | 2023 | 198 | 0.220 |
Why?
|
| Meningitis, Bacterial | 1 | 2005 | 225 | 0.210 |
Why?
|
| Dextran Sulfate | 1 | 2024 | 258 | 0.210 |
Why?
|
| Female | 82 | 2020 | 397464 | 0.210 |
Why?
|
| Models, Immunological | 4 | 2018 | 518 | 0.210 |
Why?
|
| Stress, Physiological | 1 | 2010 | 1410 | 0.210 |
Why?
|
| Prevotella melaninogenica | 6 | 1979 | 13 | 0.210 |
Why?
|
| Drug Design | 1 | 2008 | 1046 | 0.210 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2021 | 2574 | 0.210 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2010 | 1683 | 0.210 |
Why?
|
| Neutrophils | 9 | 2024 | 3785 | 0.210 |
Why?
|
| Receptors, Complement 3d | 1 | 2003 | 117 | 0.210 |
Why?
|
| Portal Vein | 1 | 2005 | 435 | 0.200 |
Why?
|
| Linoleic Acid | 1 | 2023 | 158 | 0.200 |
Why?
|
| Antigens | 4 | 2018 | 1444 | 0.200 |
Why?
|
| Lipolysis | 1 | 2023 | 211 | 0.200 |
Why?
|
| Rats, Wistar | 10 | 2004 | 1890 | 0.200 |
Why?
|
| Phenotype | 9 | 2017 | 16735 | 0.200 |
Why?
|
| Autoimmune Diseases | 2 | 2014 | 2260 | 0.200 |
Why?
|
| Anions | 1 | 2002 | 137 | 0.190 |
Why?
|
| Antibody Specificity | 10 | 2002 | 1065 | 0.190 |
Why?
|
| Signal Transduction | 9 | 2021 | 23652 | 0.190 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 2012 | 220 | 0.190 |
Why?
|
| Lymph Nodes | 1 | 2013 | 3473 | 0.190 |
Why?
|
| Cations | 1 | 2002 | 240 | 0.190 |
Why?
|
| Microbial Interactions | 2 | 2013 | 74 | 0.190 |
Why?
|
| Abdomen | 9 | 1994 | 1137 | 0.180 |
Why?
|
| Vesiculovirus | 1 | 2020 | 53 | 0.180 |
Why?
|
| Staphylococcus aureus | 5 | 2008 | 1430 | 0.180 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 11934 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2023 | 812 | 0.170 |
Why?
|
| Pantoea | 1 | 2020 | 14 | 0.170 |
Why?
|
| Bone Marrow Cells | 2 | 2020 | 2414 | 0.170 |
Why?
|
| Immunologic Factors | 1 | 2009 | 1597 | 0.170 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2020 | 86 | 0.170 |
Why?
|
| Carbohydrate Dehydrogenases | 1 | 1999 | 12 | 0.170 |
Why?
|
| Interleukin-2 | 3 | 2011 | 1895 | 0.170 |
Why?
|
| Gastrointestinal Diseases | 1 | 2008 | 1206 | 0.170 |
Why?
|
| Antigens, CD | 9 | 2015 | 4032 | 0.170 |
Why?
|
| Neutrophil Activation | 1 | 2020 | 180 | 0.170 |
Why?
|
| Interferon Type I | 2 | 2017 | 569 | 0.170 |
Why?
|
| Interinstitutional Relations | 1 | 2000 | 236 | 0.160 |
Why?
|
| Clostridium Infections | 2 | 2004 | 559 | 0.160 |
Why?
|
| Goblet Cells | 1 | 2022 | 301 | 0.160 |
Why?
|
| Digestive System | 1 | 2020 | 244 | 0.160 |
Why?
|
| Immunotherapy | 4 | 2023 | 4755 | 0.160 |
Why?
|
| Complement Activation | 5 | 1986 | 447 | 0.160 |
Why?
|
| Male | 56 | 2020 | 365249 | 0.160 |
Why?
|
| Endosomes | 4 | 2009 | 525 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 3447 | 0.160 |
Why?
|
| Feedback, Physiological | 1 | 2021 | 481 | 0.160 |
Why?
|
| Immunologic Surveillance | 2 | 2011 | 93 | 0.160 |
Why?
|
| Interferon-beta | 1 | 2020 | 349 | 0.150 |
Why?
|
| Industry | 1 | 2000 | 362 | 0.150 |
Why?
|
| Demyelinating Diseases | 1 | 2021 | 358 | 0.150 |
Why?
|
| Glucans | 1 | 1998 | 71 | 0.150 |
Why?
|
| B-Lymphocytes | 6 | 2010 | 4794 | 0.150 |
Why?
|
| Cell Proliferation | 5 | 2014 | 10486 | 0.150 |
Why?
|
| Stromal Cells | 1 | 2024 | 1337 | 0.150 |
Why?
|
| Meningococcal Vaccines | 1 | 2018 | 96 | 0.150 |
Why?
|
| Ruminococcus | 1 | 2017 | 11 | 0.150 |
Why?
|
| Complement C1 | 4 | 1986 | 31 | 0.150 |
Why?
|
| Toll-Like Receptors | 4 | 2010 | 582 | 0.150 |
Why?
|
| Blood Bactericidal Activity | 11 | 1983 | 124 | 0.150 |
Why?
|
| Gonorrhea | 5 | 1982 | 355 | 0.150 |
Why?
|
| Complement Pathway, Classical | 5 | 1986 | 91 | 0.150 |
Why?
|
| Species Specificity | 6 | 2012 | 2419 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 8 | 2024 | 9264 | 0.150 |
Why?
|
| Structure-Activity Relationship | 8 | 2002 | 3056 | 0.150 |
Why?
|
| Models, Molecular | 7 | 2021 | 5404 | 0.150 |
Why?
|
| Receptors, Interleukin-10 | 1 | 2017 | 51 | 0.150 |
Why?
|
| Apyrase | 3 | 2015 | 376 | 0.150 |
Why?
|
| Binding, Competitive | 7 | 2009 | 1142 | 0.140 |
Why?
|
| beta-Glucans | 1 | 1998 | 129 | 0.140 |
Why?
|
| Vaginosis, Bacterial | 1 | 2019 | 154 | 0.140 |
Why?
|
| Ions | 5 | 2004 | 256 | 0.140 |
Why?
|
| Hydrogen-Ion Concentration | 8 | 2008 | 2488 | 0.140 |
Why?
|
| Membrane Glycoproteins | 9 | 2012 | 3714 | 0.140 |
Why?
|
| Oxazolone | 2 | 2014 | 61 | 0.140 |
Why?
|
| Cricetinae | 6 | 2008 | 2423 | 0.140 |
Why?
|
| Adjuvants, Immunologic | 2 | 2001 | 999 | 0.140 |
Why?
|
| Receptor, IGF Type 2 | 1 | 1996 | 35 | 0.140 |
Why?
|
| Click Chemistry | 1 | 2017 | 101 | 0.140 |
Why?
|
| Th1 Cells | 4 | 2017 | 1042 | 0.140 |
Why?
|
| Antigenic Variation | 2 | 2001 | 118 | 0.140 |
Why?
|
| Feces | 4 | 2019 | 1511 | 0.130 |
Why?
|
| Mice, Inbred C3H | 4 | 2006 | 915 | 0.130 |
Why?
|
| Gene Expression Regulation, Bacterial | 5 | 2010 | 1137 | 0.130 |
Why?
|
| Peritoneal Cavity | 3 | 2003 | 135 | 0.130 |
Why?
|
| Cells, Cultured | 15 | 2017 | 19023 | 0.130 |
Why?
|
| Polymers | 2 | 2003 | 1632 | 0.130 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2017 | 120 | 0.130 |
Why?
|
| Receptors, Fc | 1 | 2020 | 538 | 0.130 |
Why?
|
| Phylogeny | 4 | 2020 | 2843 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 3 | 2013 | 7472 | 0.130 |
Why?
|
| Hydroxybutyrates | 1 | 2016 | 76 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2008 | 515 | 0.130 |
Why?
|
| Fatal Outcome | 1 | 2020 | 1836 | 0.130 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 1321 | 0.130 |
Why?
|
| Conflict of Interest | 1 | 2000 | 555 | 0.130 |
Why?
|
| Spleen | 5 | 2009 | 2294 | 0.130 |
Why?
|
| Cell Communication | 2 | 2004 | 1660 | 0.130 |
Why?
|
| Ozone | 1 | 1999 | 496 | 0.130 |
Why?
|
| Colitis, Ulcerative | 4 | 2015 | 1931 | 0.130 |
Why?
|
| Lethal Dose 50 | 3 | 2013 | 71 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 17 | 2008 | 3782 | 0.120 |
Why?
|
| Lysosomes | 2 | 2002 | 940 | 0.120 |
Why?
|
| Gene Deletion | 3 | 2013 | 2674 | 0.120 |
Why?
|
| Cytokines | 7 | 2017 | 7453 | 0.120 |
Why?
|
| Genetic Complementation Test | 2 | 2010 | 557 | 0.120 |
Why?
|
| Genome, Bacterial | 3 | 2005 | 796 | 0.120 |
Why?
|
| Lipid A | 2 | 2013 | 70 | 0.120 |
Why?
|
| Pregnancy | 24 | 2013 | 30175 | 0.120 |
Why?
|
| Inflammation | 6 | 2020 | 10869 | 0.120 |
Why?
|
| DNA, Bacterial | 6 | 2008 | 1478 | 0.120 |
Why?
|
| Crosses, Genetic | 1 | 2016 | 752 | 0.120 |
Why?
|
| Fluorescence | 1 | 2017 | 758 | 0.120 |
Why?
|
| Interleukin-1beta | 2 | 2019 | 1027 | 0.120 |
Why?
|
| Organ Culture Techniques | 1 | 2017 | 796 | 0.120 |
Why?
|
| Immunoelectrophoresis | 5 | 1995 | 94 | 0.120 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2019 | 446 | 0.120 |
Why?
|
| Models, Biological | 6 | 2010 | 9499 | 0.120 |
Why?
|
| Encephalomyelitis | 1 | 2014 | 37 | 0.120 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2017 | 547 | 0.110 |
Why?
|
| Bacillus | 1 | 1994 | 77 | 0.110 |
Why?
|
| Glycocalyx | 1 | 2015 | 99 | 0.110 |
Why?
|
| Adhesins, Bacterial | 2 | 2009 | 118 | 0.110 |
Why?
|
| Teichoic Acids | 3 | 2005 | 70 | 0.110 |
Why?
|
| Schools, Medical | 1 | 2000 | 882 | 0.110 |
Why?
|
| Chromatography, Gel | 5 | 2008 | 637 | 0.110 |
Why?
|
| Staining and Labeling | 2 | 2017 | 1081 | 0.110 |
Why?
|
| Neisseria gonorrhoeae | 5 | 1982 | 249 | 0.110 |
Why?
|
| Flow Cytometry | 5 | 2018 | 5905 | 0.110 |
Why?
|
| Amino Acid Motifs | 3 | 2005 | 930 | 0.110 |
Why?
|
| Peritonitis | 2 | 2015 | 368 | 0.110 |
Why?
|
| Protein Binding | 5 | 2024 | 9344 | 0.110 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 6 | 1997 | 781 | 0.110 |
Why?
|
| Th17 Cells | 2 | 2016 | 791 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2011 | 1855 | 0.110 |
Why?
|
| Macrophages, Peritoneal | 2 | 2005 | 244 | 0.100 |
Why?
|
| Salmonella enterica | 1 | 2013 | 76 | 0.100 |
Why?
|
| Sequence Deletion | 2 | 2001 | 1498 | 0.100 |
Why?
|
| Immunodiffusion | 7 | 1989 | 141 | 0.100 |
Why?
|
| Antigen-Antibody Reactions | 6 | 1987 | 342 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 10 | 1991 | 2475 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2024 | 4651 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2012 | 4356 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 800 | 0.100 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2019 | 823 | 0.100 |
Why?
|
| Escherichia coli Proteins | 1 | 1999 | 1058 | 0.100 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1997 | 667 | 0.100 |
Why?
|
| Yin-Yang | 1 | 2012 | 10 | 0.100 |
Why?
|
| Mesentery | 1 | 2013 | 202 | 0.100 |
Why?
|
| Lymphocyte Depletion | 1 | 2014 | 605 | 0.100 |
Why?
|
| Animal Structures | 1 | 2011 | 26 | 0.100 |
Why?
|
| Lung | 3 | 2020 | 10097 | 0.100 |
Why?
|
| Genetic Variation | 4 | 2005 | 6610 | 0.100 |
Why?
|
| Perinatology | 1 | 1991 | 63 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 2019 | 1667 | 0.100 |
Why?
|
| Breast Feeding | 1 | 2020 | 1364 | 0.090 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 1996 | 539 | 0.090 |
Why?
|
| Microscopy, Electron | 10 | 1989 | 2560 | 0.090 |
Why?
|
| Mutation | 6 | 2010 | 30266 | 0.090 |
Why?
|
| Immunologic Memory | 1 | 1998 | 1378 | 0.090 |
Why?
|
| Viral Load | 1 | 2020 | 3398 | 0.090 |
Why?
|
| CHO Cells | 4 | 2008 | 1380 | 0.090 |
Why?
|
| Macrophage Activation | 2 | 2005 | 556 | 0.090 |
Why?
|
| Probiotics | 2 | 2016 | 382 | 0.090 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 761 | 0.090 |
Why?
|
| Molecular Mimicry | 2 | 2014 | 213 | 0.090 |
Why?
|
| Mitogens | 2 | 1999 | 229 | 0.090 |
Why?
|
| Colorectal Surgery | 1 | 2012 | 125 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 10 | 1991 | 1731 | 0.090 |
Why?
|
| Guinea Pigs | 4 | 2004 | 1309 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2013 | 10115 | 0.090 |
Why?
|
| Guanosine Tetraphosphate | 1 | 2009 | 11 | 0.090 |
Why?
|
| Receptors, Chemokine | 1 | 2013 | 652 | 0.080 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 250 | 0.080 |
Why?
|
| Biocatalysis | 1 | 2010 | 168 | 0.080 |
Why?
|
| Mucous Membrane | 1 | 2013 | 659 | 0.080 |
Why?
|
| Oxidation-Reduction | 4 | 2010 | 2226 | 0.080 |
Why?
|
| Microbial Viability | 1 | 2011 | 235 | 0.080 |
Why?
|
| Immunoblotting | 4 | 1995 | 1647 | 0.080 |
Why?
|
| Host-Parasite Interactions | 1 | 2012 | 303 | 0.080 |
Why?
|
| Cell Line | 4 | 2019 | 15603 | 0.080 |
Why?
|
| Helicobacter | 1 | 2009 | 111 | 0.080 |
Why?
|
| Colorectal Neoplasms | 2 | 2024 | 6982 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2277 | 0.080 |
Why?
|
| Th2 Cells | 2 | 2017 | 1079 | 0.080 |
Why?
|
| Plants | 1 | 2010 | 332 | 0.080 |
Why?
|
| Cell Count | 1 | 2013 | 1833 | 0.080 |
Why?
|
| Mothers | 1 | 2020 | 2211 | 0.080 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 4 | 2001 | 354 | 0.080 |
Why?
|
| Nitric Oxide | 2 | 2009 | 2149 | 0.080 |
Why?
|
| Mucus | 2 | 2022 | 346 | 0.080 |
Why?
|
| Chemokines, CXC | 2 | 2008 | 420 | 0.080 |
Why?
|
| Injections, Intradermal | 1 | 2008 | 117 | 0.080 |
Why?
|
| Immune Tolerance | 2 | 2016 | 2323 | 0.080 |
Why?
|
| Hyperthermia, Induced | 1 | 2012 | 416 | 0.080 |
Why?
|
| Carrageenan | 1 | 1988 | 71 | 0.080 |
Why?
|
| Molecular Structure | 7 | 1995 | 1885 | 0.080 |
Why?
|
| Salts | 1 | 2008 | 61 | 0.080 |
Why?
|
| Amino Acids | 4 | 2010 | 1716 | 0.080 |
Why?
|
| Cell Survival | 2 | 2017 | 5794 | 0.080 |
Why?
|
| Base Sequence | 8 | 2005 | 12430 | 0.080 |
Why?
|
| HLA-D Antigens | 1 | 2008 | 130 | 0.080 |
Why?
|
| Enterococcus faecium | 2 | 1999 | 101 | 0.080 |
Why?
|
| Sensory Receptor Cells | 1 | 2013 | 508 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 5342 | 0.070 |
Why?
|
| Receptors, Cell Surface | 5 | 2005 | 2820 | 0.070 |
Why?
|
| Escherichia coli | 6 | 2013 | 4212 | 0.070 |
Why?
|
| Interleukin-4 | 1 | 2011 | 1157 | 0.070 |
Why?
|
| Cell Wall | 8 | 2000 | 421 | 0.070 |
Why?
|
| Enterococcus faecalis | 2 | 1999 | 244 | 0.070 |
Why?
|
| Mannose-Binding Lectin | 1 | 2008 | 146 | 0.070 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2010 | 497 | 0.070 |
Why?
|
| Complement System Proteins | 9 | 1986 | 738 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 4 | 2015 | 1625 | 0.070 |
Why?
|
| Bacteroidetes | 2 | 2019 | 84 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1933 | 0.070 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2011 | 1963 | 0.070 |
Why?
|
| Rats, Inbred Lew | 4 | 2004 | 1163 | 0.070 |
Why?
|
| Hexuronic Acids | 2 | 1984 | 145 | 0.070 |
Why?
|
| Body Weight | 1 | 2017 | 4628 | 0.070 |
Why?
|
| Epithelial Cells | 3 | 2019 | 3701 | 0.070 |
Why?
|
| Mesocricetus | 2 | 2004 | 256 | 0.070 |
Why?
|
| Cricetulus | 1 | 2008 | 813 | 0.070 |
Why?
|
| Papio | 2 | 2000 | 672 | 0.070 |
Why?
|
| Bacterial Adhesion | 2 | 2005 | 305 | 0.070 |
Why?
|
| History, 20th Century | 4 | 2004 | 2771 | 0.060 |
Why?
|
| Vancomycin | 2 | 1999 | 505 | 0.060 |
Why?
|
| Proteins | 2 | 2001 | 6011 | 0.060 |
Why?
|
| Transcription Factor RelA | 1 | 2006 | 254 | 0.060 |
Why?
|
| Receptors, Complement | 1 | 1986 | 254 | 0.060 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2022 | 328 | 0.060 |
Why?
|
| Respiratory Burst | 1 | 2005 | 110 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2009 | 6131 | 0.060 |
Why?
|
| Amino Acid Sequence | 6 | 2010 | 13427 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 3 | 2024 | 4415 | 0.060 |
Why?
|
| Fever of Unknown Origin | 1 | 2005 | 94 | 0.060 |
Why?
|
| Antibody Affinity | 3 | 2002 | 253 | 0.060 |
Why?
|
| Legionella | 2 | 1982 | 27 | 0.060 |
Why?
|
| Interleukin-8 | 2 | 2019 | 705 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2000 | 3463 | 0.060 |
Why?
|
| Anorexia | 1 | 2005 | 152 | 0.060 |
Why?
|
| Thrombophlebitis | 1 | 2005 | 289 | 0.060 |
Why?
|
| Pelvic Inflammatory Disease | 3 | 1981 | 95 | 0.060 |
Why?
|
| Appendix | 1 | 2005 | 109 | 0.060 |
Why?
|
| Complement Pathway, Alternative | 3 | 1985 | 113 | 0.060 |
Why?
|
| Sweating | 1 | 2005 | 155 | 0.060 |
Why?
|
| Glycoproteins | 2 | 1995 | 2202 | 0.060 |
Why?
|
| Sequence Analysis | 3 | 2000 | 240 | 0.060 |
Why?
|
| Hematologic Tests | 1 | 2005 | 239 | 0.060 |
Why?
|
| Melanoma | 1 | 2023 | 5709 | 0.060 |
Why?
|
| Endotoxins | 4 | 1982 | 520 | 0.060 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2004 | 94 | 0.060 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 1839 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2000 | 6085 | 0.060 |
Why?
|
| Adult | 32 | 2019 | 223818 | 0.060 |
Why?
|
| Macaca mulatta | 2 | 2008 | 2365 | 0.050 |
Why?
|
| Yersinia enterocolitica | 1 | 1983 | 13 | 0.050 |
Why?
|
| Blood Chemical Analysis | 1 | 2005 | 436 | 0.050 |
Why?
|
| Health | 1 | 2006 | 398 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 9564 | 0.050 |
Why?
|
| Clonal Anergy | 1 | 2004 | 169 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1994 | 2682 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2012 | 2258 | 0.050 |
Why?
|
| Meningitis | 4 | 1981 | 219 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8200 | 0.050 |
Why?
|
| Anaerobiosis | 2 | 2019 | 140 | 0.050 |
Why?
|
| Hypertension, Portal | 1 | 2005 | 230 | 0.050 |
Why?
|
| Receptor Activity-Modifying Protein 1 | 1 | 2022 | 18 | 0.050 |
Why?
|
| Cyclobutanes | 1 | 2003 | 57 | 0.050 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2003 | 50 | 0.050 |
Why?
|
| Drosophila Proteins | 2 | 2002 | 1712 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 4 | 2007 | 4784 | 0.050 |
Why?
|
| Endocytosis | 2 | 2004 | 959 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 5 | 1987 | 513 | 0.050 |
Why?
|
| CD40 Ligand | 2 | 2005 | 528 | 0.050 |
Why?
|
| Cecum | 2 | 2002 | 231 | 0.050 |
Why?
|
| Ligands | 2 | 2024 | 3283 | 0.050 |
Why?
|
| Plasmids | 4 | 2005 | 2269 | 0.050 |
Why?
|
| Alum Compounds | 1 | 2001 | 35 | 0.050 |
Why?
|
| Cell Compartmentation | 1 | 2002 | 383 | 0.050 |
Why?
|
| Lymphokines | 1 | 1985 | 927 | 0.050 |
Why?
|
| Glycosylation | 1 | 2005 | 1101 | 0.050 |
Why?
|
| Tissue Adhesions | 2 | 2002 | 223 | 0.050 |
Why?
|
| Multigene Family | 2 | 2005 | 1082 | 0.050 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2023 | 263 | 0.050 |
Why?
|
| Maternal-Fetal Exchange | 3 | 1981 | 456 | 0.050 |
Why?
|
| Vagina | 4 | 1999 | 848 | 0.050 |
Why?
|
| Insulin | 1 | 2016 | 6610 | 0.050 |
Why?
|
| Liver | 2 | 2008 | 7579 | 0.050 |
Why?
|
| Cholesterol | 1 | 2010 | 2913 | 0.050 |
Why?
|
| Cloning, Molecular | 5 | 2001 | 4168 | 0.050 |
Why?
|
| Binding Sites, Antibody | 4 | 1989 | 340 | 0.050 |
Why?
|
| Osteopetrosis | 1 | 2001 | 42 | 0.050 |
Why?
|
| Pancreatitis | 1 | 1988 | 1087 | 0.050 |
Why?
|
| Technology Transfer | 1 | 2000 | 42 | 0.050 |
Why?
|
| Smallpox | 1 | 2000 | 43 | 0.040 |
Why?
|
| Fetus | 2 | 2019 | 1882 | 0.040 |
Why?
|
| Haemophilus Infections | 1 | 1980 | 94 | 0.040 |
Why?
|
| Kinetics | 6 | 2003 | 6334 | 0.040 |
Why?
|
| History, 18th Century | 1 | 2000 | 206 | 0.040 |
Why?
|
| Haemophilus influenzae | 1 | 1980 | 177 | 0.040 |
Why?
|
| Buffers | 1 | 2000 | 143 | 0.040 |
Why?
|
| Bacteremia | 2 | 1998 | 985 | 0.040 |
Why?
|
| Germinal Center | 1 | 2003 | 380 | 0.040 |
Why?
|
| Receptors, Immunologic | 2 | 2005 | 1418 | 0.040 |
Why?
|
| Carbohydrate Epimerases | 1 | 1999 | 46 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2024 | 875 | 0.040 |
Why?
|
| Chemokine CXCL5 | 1 | 2019 | 27 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2008 | 3163 | 0.040 |
Why?
|
| Chloride Channels | 1 | 2001 | 222 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2000 | 361 | 0.040 |
Why?
|
| Mice, Inbred CBA | 1 | 2020 | 438 | 0.040 |
Why?
|
| Gram-Negative Anaerobic Bacteria | 1 | 1979 | 15 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2002 | 921 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 1998 | 1769 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2001 | 407 | 0.040 |
Why?
|
| Surgical Wound Infection | 2 | 2008 | 1546 | 0.040 |
Why?
|
| Thyrotropin | 1 | 1983 | 834 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 1999 | 6512 | 0.040 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 1398 | 0.040 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2000 | 173 | 0.040 |
Why?
|
| Empyema | 1 | 1979 | 41 | 0.040 |
Why?
|
| Immunologic Techniques | 4 | 1983 | 213 | 0.040 |
Why?
|
| Multiple Sclerosis | 2 | 2014 | 3250 | 0.040 |
Why?
|
| Legionnaires' Disease | 1 | 1979 | 50 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 1999 | 363 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 1999 | 413 | 0.040 |
Why?
|
| Arabidopsis Proteins | 1 | 2000 | 264 | 0.040 |
Why?
|
| Gene Expression | 3 | 2006 | 7602 | 0.040 |
Why?
|
| Serum Albumin | 1 | 2002 | 677 | 0.040 |
Why?
|
| Nociceptors | 1 | 2022 | 460 | 0.040 |
Why?
|
| Solutions | 1 | 1999 | 410 | 0.040 |
Why?
|
| Precipitin Tests | 4 | 1991 | 816 | 0.040 |
Why?
|
| Diet | 1 | 2016 | 8090 | 0.040 |
Why?
|
| Technology | 1 | 2021 | 296 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2023 | 2941 | 0.040 |
Why?
|
| Appendicitis | 1 | 2005 | 689 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2019 | 365 | 0.040 |
Why?
|
| DNA Transposable Elements | 4 | 1991 | 764 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2001 | 377 | 0.040 |
Why?
|
| Fibrosis | 1 | 2005 | 2081 | 0.040 |
Why?
|
| Colony Count, Microbial | 2 | 2008 | 328 | 0.040 |
Why?
|
| Organizational Policy | 1 | 2000 | 434 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2006 | 2911 | 0.040 |
Why?
|
| History, 19th Century | 1 | 2000 | 715 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 2749 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2000 | 376 | 0.040 |
Why?
|
| Otitis Media | 1 | 1980 | 288 | 0.040 |
Why?
|
| Methylation | 5 | 1991 | 1078 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2010 | 2297 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2010 | 3591 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 1991 | 2965 | 0.040 |
Why?
|
| Bone Development | 1 | 2001 | 473 | 0.040 |
Why?
|
| Solubility | 1 | 1999 | 1087 | 0.040 |
Why?
|
| Wound Infection | 2 | 1979 | 243 | 0.040 |
Why?
|
| Adolescent | 11 | 2004 | 89247 | 0.040 |
Why?
|
| Immunity, Active | 2 | 1989 | 58 | 0.040 |
Why?
|
| Microglia | 1 | 2006 | 1376 | 0.040 |
Why?
|
| Neurodegenerative Diseases | 1 | 2006 | 1094 | 0.030 |
Why?
|
| Asthma | 2 | 2016 | 6293 | 0.030 |
Why?
|
| Osteoclasts | 1 | 2001 | 713 | 0.030 |
Why?
|
| Restriction Mapping | 2 | 1994 | 849 | 0.030 |
Why?
|
| Adsorption | 3 | 2001 | 198 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 59738 | 0.030 |
Why?
|
| Immunochemistry | 2 | 1991 | 116 | 0.030 |
Why?
|
| Cathepsin D | 1 | 1996 | 59 | 0.030 |
Why?
|
| Dimerization | 1 | 1998 | 886 | 0.030 |
Why?
|
| Immunoassay | 4 | 1988 | 746 | 0.030 |
Why?
|
| Biodiversity | 1 | 2019 | 345 | 0.030 |
Why?
|
| Middle Aged | 10 | 2020 | 223740 | 0.030 |
Why?
|
| Transfection | 3 | 2001 | 5763 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 1989 | 446 | 0.030 |
Why?
|
| Endopeptidases | 3 | 2000 | 764 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 1999 | 818 | 0.030 |
Why?
|
| Bacteriological Techniques | 3 | 2010 | 277 | 0.030 |
Why?
|
| Immunophenotyping | 2 | 2015 | 1866 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 1998 | 557 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1996 | 767 | 0.030 |
Why?
|
| Pituitary Gland | 1 | 1998 | 634 | 0.030 |
Why?
|
| Amino Sugars | 3 | 1984 | 39 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 1998 | 692 | 0.030 |
Why?
|
| Galactose | 5 | 1995 | 300 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1996 | 867 | 0.030 |
Why?
|
| Brain | 2 | 2021 | 27476 | 0.030 |
Why?
|
| Transformation, Bacterial | 1 | 1994 | 79 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1608 | 0.030 |
Why?
|
| Mice, Nude | 2 | 1999 | 3631 | 0.030 |
Why?
|
| Electrochemistry | 1 | 1994 | 146 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 1994 | 337 | 0.030 |
Why?
|
| Arthritis, Experimental | 1 | 2016 | 293 | 0.030 |
Why?
|
| Radiography | 1 | 2005 | 6991 | 0.030 |
Why?
|
| Disease Progression | 1 | 2011 | 13677 | 0.030 |
Why?
|
| Neuraminidase | 4 | 1992 | 196 | 0.030 |
Why?
|
| Transformation, Genetic | 1 | 1994 | 194 | 0.030 |
Why?
|
| Safety | 1 | 1999 | 1159 | 0.030 |
Why?
|
| Toll-Like Receptor 6 | 2 | 2005 | 29 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 2005 | 15889 | 0.030 |
Why?
|
| Trypsin | 1 | 1994 | 491 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 1995 | 228 | 0.030 |
Why?
|
| Chromatography | 2 | 1972 | 189 | 0.030 |
Why?
|
| Weight Loss | 1 | 2005 | 2720 | 0.030 |
Why?
|
| Obesity | 1 | 2016 | 13087 | 0.030 |
Why?
|
| Mutagenesis | 3 | 2005 | 1229 | 0.030 |
Why?
|
| Meningitis, Meningococcal | 1 | 1973 | 43 | 0.030 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2017 | 327 | 0.030 |
Why?
|
| Intermediate-Conductance Calcium-Activated Potassium Channels | 1 | 2013 | 45 | 0.030 |
Why?
|
| Isoelectric Focusing | 1 | 1992 | 149 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1996 | 1356 | 0.030 |
Why?
|
| Hypothalamus | 1 | 1998 | 1004 | 0.030 |
Why?
|
| Carbon Isotopes | 5 | 1973 | 458 | 0.030 |
Why?
|
| Infant | 9 | 1999 | 36541 | 0.030 |
Why?
|
| Chemokine CXCL6 | 1 | 2012 | 14 | 0.030 |
Why?
|
| Chemical Precipitation | 2 | 1985 | 175 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1992 | 316 | 0.030 |
Why?
|
| Salmonella typhi | 1 | 1993 | 200 | 0.020 |
Why?
|
| Receptors, CXCR | 1 | 2012 | 52 | 0.020 |
Why?
|
| Leukocytes | 1 | 1980 | 2034 | 0.020 |
Why?
|
| Peptides | 2 | 2004 | 4353 | 0.020 |
Why?
|
| Reference Standards | 1 | 1995 | 1014 | 0.020 |
Why?
|
| Biological Transport | 1 | 1996 | 2085 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2002 | 6856 | 0.020 |
Why?
|
| Blotting, Western | 3 | 2001 | 5035 | 0.020 |
Why?
|
| DNA Primers | 1 | 1996 | 2827 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2001 | 1839 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 3 | 2010 | 5801 | 0.020 |
Why?
|
| Immunotoxins | 1 | 1992 | 175 | 0.020 |
Why?
|
| Acute-Phase Proteins | 1 | 2012 | 252 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1991 | 293 | 0.020 |
Why?
|
| Calcitonin | 1 | 2012 | 329 | 0.020 |
Why?
|
| Dissection | 1 | 2013 | 299 | 0.020 |
Why?
|
| Hexoses | 3 | 1984 | 29 | 0.020 |
Why?
|
| Radioimmunoassay | 4 | 1984 | 862 | 0.020 |
Why?
|
| Aged | 4 | 2020 | 171790 | 0.020 |
Why?
|
| Rhamnose | 3 | 1995 | 18 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2013 | 927 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 4 | 1973 | 87 | 0.020 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1989 | 49 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 13020 | 0.020 |
Why?
|
| Antibodies, Neoplasm | 1 | 1991 | 283 | 0.020 |
Why?
|
| Integrin alpha Chains | 1 | 2010 | 93 | 0.020 |
Why?
|
| Micropore Filters | 1 | 1989 | 22 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2004 | 12469 | 0.020 |
Why?
|
| Point Mutation | 1 | 1994 | 1595 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2000 | 3138 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1989 | 199 | 0.020 |
Why?
|
| HMGB1 Protein | 1 | 2010 | 141 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1996 | 1360 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2012 | 1585 | 0.020 |
Why?
|
| Penicillins | 1 | 1991 | 406 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 797 | 0.020 |
Why?
|
| Complement C2 | 3 | 1982 | 45 | 0.020 |
Why?
|
| Peritoneal Dialysis | 1 | 1989 | 160 | 0.020 |
Why?
|
| Glucosamine | 3 | 1978 | 128 | 0.020 |
Why?
|
| RNA Interference | 1 | 2017 | 2835 | 0.020 |
Why?
|
| beta-Galactosidase | 2 | 1990 | 575 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2012 | 1135 | 0.020 |
Why?
|
| Epithelium | 1 | 2013 | 1607 | 0.020 |
Why?
|
| Glucose | 6 | 1995 | 4352 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 3613 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 1305 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 1997 | 3414 | 0.020 |
Why?
|
| Prognosis | 1 | 2008 | 30044 | 0.020 |
Why?
|
| Hemagglutination Tests | 5 | 1973 | 76 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2000 | 12809 | 0.020 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2008 | 146 | 0.020 |
Why?
|
| United States | 4 | 2007 | 73180 | 0.020 |
Why?
|
| Optical Rotation | 1 | 1987 | 11 | 0.020 |
Why?
|
| Oxygen | 1 | 2019 | 4273 | 0.020 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2009 | 366 | 0.020 |
Why?
|
| Uronic Acids | 2 | 1984 | 17 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 1987 | 455 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 1987 | 212 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 7609 | 0.020 |
Why?
|
| Recombination, Genetic | 2 | 2005 | 1526 | 0.020 |
Why?
|
| Carrier State | 3 | 1981 | 529 | 0.020 |
Why?
|
| Pharynx | 2 | 1980 | 436 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2012 | 1336 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2016 | 1173 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1987 | 1057 | 0.020 |
Why?
|
| Colorimetry | 1 | 1987 | 151 | 0.020 |
Why?
|
| Birds | 1 | 1987 | 166 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2009 | 524 | 0.020 |
Why?
|
| Complement C1 Inactivator Proteins | 1 | 1986 | 89 | 0.020 |
Why?
|
| Fever | 2 | 2012 | 1620 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1988 | 585 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 2 | 1999 | 829 | 0.020 |
Why?
|
| Sheep | 2 | 1986 | 1451 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1991 | 1445 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 2 | 1979 | 320 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1996 | 4178 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2008 | 395 | 0.020 |
Why?
|
| Chromatography, Gas | 2 | 1987 | 150 | 0.020 |
Why?
|
| Insect Proteins | 1 | 1987 | 253 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1989 | 1609 | 0.020 |
Why?
|
| Suppressor Factors, Immunologic | 1 | 1985 | 68 | 0.020 |
Why?
|
| NF-kappa B | 2 | 2005 | 2492 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 1982 | 7885 | 0.020 |
Why?
|
| Action Potentials | 1 | 2013 | 1838 | 0.020 |
Why?
|
| Phosphatidic Acids | 1 | 1985 | 50 | 0.020 |
Why?
|
| Surface Properties | 1 | 2008 | 1169 | 0.020 |
Why?
|
| Inflammation Mediators | 2 | 2005 | 1890 | 0.010 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 9549 | 0.010 |
Why?
|
| Drug Stability | 1 | 1985 | 292 | 0.010 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2005 | 148 | 0.010 |
Why?
|
| Acetylglucosamine | 2 | 1995 | 189 | 0.010 |
Why?
|
| Puerperal Infection | 2 | 1981 | 44 | 0.010 |
Why?
|
| Hemolysis | 1 | 1986 | 417 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 1990 | 2183 | 0.010 |
Why?
|
| Receptors, Thyrotropin | 1 | 1983 | 45 | 0.010 |
Why?
|
| STAT4 Transcription Factor | 1 | 2003 | 94 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4593 | 0.010 |
Why?
|
| Hydrolysis | 2 | 1988 | 646 | 0.010 |
Why?
|
| Aging | 2 | 2012 | 8765 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 1984 | 433 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1987 | 1251 | 0.010 |
Why?
|
| Metronidazole | 2 | 1982 | 236 | 0.010 |
Why?
|
| Absorption | 2 | 1979 | 243 | 0.010 |
Why?
|
| Monosaccharides | 1 | 1983 | 64 | 0.010 |
Why?
|
| Hybridomas | 1 | 2004 | 444 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1984 | 2087 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 2003 | 196 | 0.010 |
Why?
|
| Elapid Venoms | 1 | 1982 | 40 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 201 | 0.010 |
Why?
|
| Alanine | 1 | 2005 | 614 | 0.010 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2002 | 58 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2001 | 3744 | 0.010 |
Why?
|
| Antibody-Producing Cells | 1 | 1982 | 140 | 0.010 |
Why?
|
| Biological Assay | 1 | 1985 | 628 | 0.010 |
Why?
|
| Oligodendroglia | 1 | 2006 | 540 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3233 | 0.010 |
Why?
|
| Lymphocyte Antigen 96 | 1 | 2001 | 21 | 0.010 |
Why?
|
| Static Electricity | 1 | 2002 | 261 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2013 | 2029 | 0.010 |
Why?
|
| Kanamycin | 1 | 1982 | 63 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2010 | 4042 | 0.010 |
Why?
|
| Heptoses | 3 | 1976 | 8 | 0.010 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2001 | 48 | 0.010 |
Why?
|
| Macaca | 1 | 1983 | 417 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2016 | 3982 | 0.010 |
Why?
|
| Binding Sites | 2 | 1983 | 6023 | 0.010 |
Why?
|
| Phagocytes | 1 | 1983 | 294 | 0.010 |
Why?
|
| Genotype | 1 | 1996 | 13048 | 0.010 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2002 | 199 | 0.010 |
Why?
|
| Chromosome Inversion | 1 | 2001 | 119 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2005 | 2179 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2008 | 65485 | 0.010 |
Why?
|
| Age Factors | 3 | 2016 | 18454 | 0.010 |
Why?
|
| Thermodynamics | 1 | 2002 | 591 | 0.010 |
Why?
|
| Consumer Product Safety | 1 | 2001 | 122 | 0.010 |
Why?
|
| Cell Surface Extensions | 1 | 2001 | 66 | 0.010 |
Why?
|
| Peritoneum | 2 | 1982 | 231 | 0.010 |
Why?
|
| Protein Folding | 1 | 2005 | 871 | 0.010 |
Why?
|
| Chemical Fractionation | 1 | 1980 | 60 | 0.010 |
Why?
|
| Cell Death | 1 | 2006 | 1682 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 4980 | 0.010 |
Why?
|
| Tyrosine | 1 | 2005 | 1427 | 0.010 |
Why?
|
| Biological Factors | 1 | 2001 | 158 | 0.010 |
Why?
|
| Splenectomy | 1 | 1982 | 392 | 0.010 |
Why?
|
| Integrin beta3 | 1 | 2001 | 120 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1996 | 14751 | 0.010 |
Why?
|
| Fetal Blood | 3 | 1982 | 1360 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2000 | 317 | 0.010 |
Why?
|
| Acetylglucosaminidase | 1 | 2000 | 66 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 1980 | 351 | 0.010 |
Why?
|
| Precipitins | 1 | 1979 | 4 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2001 | 463 | 0.010 |
Why?
|
| Biopolymers | 1 | 2001 | 183 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2001 | 283 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2002 | 508 | 0.010 |
Why?
|
| Ferritins | 2 | 1982 | 600 | 0.010 |
Why?
|
| Young Adult | 2 | 2019 | 60110 | 0.010 |
Why?
|
| Goats | 1 | 1979 | 166 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 1979 | 144 | 0.010 |
Why?
|
| Time Factors | 7 | 1984 | 40266 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15955 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2001 | 564 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2008 | 17174 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 4148 | 0.010 |
Why?
|
| Vulvitis | 1 | 1979 | 8 | 0.010 |
Why?
|
| Subphrenic Abscess | 1 | 1979 | 22 | 0.010 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2001 | 303 | 0.010 |
Why?
|
| Leg Dermatoses | 1 | 1979 | 20 | 0.010 |
Why?
|
| Ruthenium Red | 1 | 1978 | 19 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 1553 | 0.010 |
Why?
|
| Pneumococcal Infections | 1 | 2004 | 529 | 0.010 |
Why?
|
| Endometritis | 1 | 1979 | 49 | 0.010 |
Why?
|
| Immunization, Secondary | 1 | 2001 | 373 | 0.010 |
Why?
|
| Membranes | 1 | 1979 | 164 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2000 | 8758 | 0.010 |
Why?
|
| Organelles | 1 | 2001 | 265 | 0.010 |
Why?
|
| Exotoxins | 1 | 1979 | 123 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1978 | 153 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1979 | 247 | 0.010 |
Why?
|
| Genital Diseases, Female | 1 | 1980 | 192 | 0.010 |
Why?
|
| Caprylates | 1 | 1979 | 115 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1978 | 486 | 0.010 |
Why?
|
| Astrocytes | 1 | 2006 | 1349 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 1 | 1979 | 148 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2000 | 731 | 0.010 |
Why?
|
| Dermatitis | 1 | 1980 | 203 | 0.010 |
Why?
|
| Pyramidal Cells | 1 | 2000 | 367 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1978 | 278 | 0.010 |
Why?
|
| Culture Media | 2 | 1980 | 898 | 0.010 |
Why?
|
| Clostridium perfringens | 2 | 1979 | 29 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1981 | 855 | 0.010 |
Why?
|
| Isoantibodies | 1 | 1981 | 681 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2012 | 4432 | 0.010 |
Why?
|
| Apoptosis | 2 | 2006 | 9528 | 0.010 |
Why?
|
| Haplorhini | 1 | 1978 | 524 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1997 | 224 | 0.010 |
Why?
|
| Optic Nerve | 1 | 2001 | 571 | 0.010 |
Why?
|
| Epididymitis | 1 | 1977 | 37 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1979 | 566 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 2001 | 907 | 0.010 |
Why?
|
| Bone Resorption | 1 | 2001 | 728 | 0.010 |
Why?
|
| Shwartzman Phenomenon | 1 | 1976 | 9 | 0.010 |
Why?
|
| Chick Embryo | 2 | 1976 | 975 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2001 | 1524 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 1904 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1986 | 2421 | 0.010 |
Why?
|
| Convalescence | 1 | 1977 | 109 | 0.010 |
Why?
|
| Arachnoid | 1 | 1976 | 50 | 0.010 |
Why?
|
| Retinal Degeneration | 1 | 2001 | 414 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2001 | 842 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2002 | 1078 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2001 | 1505 | 0.010 |
Why?
|
| Arthritis, Infectious | 1 | 1980 | 348 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 2001 | 751 | 0.010 |
Why?
|
| Chromatography, Paper | 1 | 1976 | 76 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1998 | 619 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2016 | 12174 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 1976 | 139 | 0.010 |
Why?
|
| Enterobacter | 1 | 1995 | 44 | 0.010 |
Why?
|
| Skin Tests | 1 | 1978 | 639 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2000 | 1970 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22294 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 2003 | 9618 | 0.010 |
Why?
|
| Protein Transport | 1 | 2001 | 1956 | 0.010 |
Why?
|
| Burns | 1 | 1987 | 1901 | 0.010 |
Why?
|
| Fucose | 1 | 1995 | 122 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2001 | 1676 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 1973 | 0.010 |
Why?
|
| Hysterectomy | 1 | 1980 | 866 | 0.010 |
Why?
|
| Blood | 1 | 1977 | 597 | 0.010 |
Why?
|
| Periodontitis | 1 | 1979 | 577 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2000 | 1133 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1998 | 1133 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3775 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 542 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 3811 | 0.010 |
Why?
|
| Cattle | 1 | 1979 | 3820 | 0.010 |
Why?
|
| Abdominal Injuries | 1 | 1977 | 362 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 4862 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1991 | 5195 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2003 | 2858 | 0.010 |
Why?
|
| Autoanalysis | 1 | 1973 | 70 | 0.010 |
Why?
|
| Antigens, Ly | 2 | 1986 | 296 | 0.010 |
Why?
|
| Hexosamines | 1 | 1973 | 38 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1979 | 1883 | 0.010 |
Why?
|
| Computational Biology | 1 | 2005 | 3562 | 0.010 |
Why?
|
| TATA Box | 1 | 1992 | 127 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11684 | 0.010 |
Why?
|
| Research Design | 1 | 1988 | 6213 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1992 | 274 | 0.010 |
Why?
|
| Immunotherapy, Active | 1 | 1992 | 58 | 0.010 |
Why?
|
| Methods | 1 | 1972 | 1066 | 0.010 |
Why?
|
| Communicable Diseases | 2 | 1990 | 873 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1972 | 530 | 0.010 |
Why?
|
| Filtration | 1 | 1972 | 228 | 0.010 |
Why?
|
| Cell Division | 1 | 1999 | 4478 | 0.010 |
Why?
|
| Acute Disease | 2 | 1981 | 7245 | 0.010 |
Why?
|
| Autoradiography | 1 | 1972 | 732 | 0.010 |
Why?
|
| RNA | 1 | 2001 | 2727 | 0.010 |
Why?
|
| Cell Movement | 1 | 2003 | 5216 | 0.010 |
Why?
|
| Acrylamides | 1 | 1972 | 261 | 0.010 |
Why?
|
| Meningococcal Infections | 1 | 1971 | 78 | 0.010 |
Why?
|
| Dextrans | 1 | 1972 | 574 | 0.010 |
Why?
|
| Hemolysin Proteins | 1 | 1990 | 113 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1991 | 455 | 0.010 |
Why?
|
| Peptide Fragments | 2 | 1997 | 5150 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1998 | 1842 | 0.010 |
Why?
|
| Retina | 1 | 2001 | 2661 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1990 | 777 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10778 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2002 | 6289 | 0.010 |
Why?
|
| Periodicals as Topic | 2 | 1990 | 1470 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2013 | 54950 | 0.000 |
Why?
|
| Enterobacteriaceae | 2 | 1981 | 161 | 0.000 |
Why?
|
| Societies, Medical | 2 | 1990 | 3967 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 11119 | 0.000 |
Why?
|
| Latex Fixation Tests | 2 | 1979 | 29 | 0.000 |
Why?
|
| Amyloid beta-Peptides | 1 | 2000 | 3912 | 0.000 |
Why?
|
| Neurons | 1 | 2006 | 9524 | 0.000 |
Why?
|
| Clone Cells | 1 | 1990 | 1670 | 0.000 |
Why?
|
| Lipids | 1 | 1978 | 3345 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1977 | 3216 | 0.000 |
Why?
|
| Glioma | 1 | 2000 | 3532 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1997 | 3580 | 0.000 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 1984 | 33 | 0.000 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1984 | 52 | 0.000 |
Why?
|
| Risk Factors | 1 | 1991 | 74971 | 0.000 |
Why?
|
| Wounds and Injuries | 1 | 1977 | 2517 | 0.000 |
Why?
|
| Serum Globulins | 1 | 1983 | 23 | 0.000 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1984 | 171 | 0.000 |
Why?
|
| Neuraminic Acids | 2 | 1972 | 16 | 0.000 |
Why?
|
| Pain | 1 | 1998 | 5100 | 0.000 |
Why?
|
| Agglutinins | 1 | 1981 | 28 | 0.000 |
Why?
|
| Complement C3b | 1 | 1982 | 98 | 0.000 |
Why?
|
| Complement C4 | 1 | 1982 | 216 | 0.000 |
Why?
|
| Luminescent Measurements | 1 | 1983 | 342 | 0.000 |
Why?
|
| H-2 Antigens | 1 | 1982 | 359 | 0.000 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1992 | 1519 | 0.000 |
Why?
|
| Chlamydia | 1 | 1981 | 33 | 0.000 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1983 | 660 | 0.000 |
Why?
|
| Staphylococcus | 1 | 1980 | 146 | 0.000 |
Why?
|
| Injections, Subcutaneous | 2 | 1972 | 687 | 0.000 |
Why?
|
| Child, Preschool | 2 | 1980 | 42684 | 0.000 |
Why?
|
| Counterimmunoelectrophoresis | 1 | 1979 | 14 | 0.000 |
Why?
|
| Chloramphenicol | 1 | 1979 | 67 | 0.000 |
Why?
|
| Cecal Diseases | 1 | 1979 | 49 | 0.000 |
Why?
|
| ABO Blood-Group System | 1 | 1981 | 381 | 0.000 |
Why?
|
| Peptococcus | 1 | 1978 | 5 | 0.000 |
Why?
|
| Eubacterium | 1 | 1978 | 23 | 0.000 |
Why?
|
| Fusobacterium | 1 | 1978 | 56 | 0.000 |
Why?
|
| Cellulitis | 1 | 1980 | 206 | 0.000 |
Why?
|
| Barium Sulfate | 1 | 1978 | 180 | 0.000 |
Why?
|
| Texas | 1 | 1979 | 410 | 0.000 |
Why?
|
| Anus Diseases | 1 | 1977 | 54 | 0.000 |
Why?
|
| Gentamicins | 1 | 1978 | 244 | 0.000 |
Why?
|
| Vaginal Diseases | 1 | 1977 | 103 | 0.000 |
Why?
|
| Pharyngeal Diseases | 1 | 1977 | 134 | 0.000 |
Why?
|
| NAD | 1 | 1980 | 618 | 0.000 |
Why?
|
| Intestinal Perforation | 1 | 1978 | 254 | 0.000 |
Why?
|
| Mannose | 1 | 1976 | 122 | 0.000 |
Why?
|
| Parity | 1 | 1979 | 930 | 0.000 |
Why?
|
| Pelvis | 1 | 1980 | 738 | 0.000 |
Why?
|
| Child | 2 | 1980 | 80969 | 0.000 |
Why?
|
| Family Characteristics | 1 | 1979 | 1002 | 0.000 |
Why?
|
| Immune Adherence Reaction | 1 | 1972 | 29 | 0.000 |
Why?
|
| Osteomyelitis | 1 | 1977 | 408 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1972 | 298 | 0.000 |
Why?
|
| Arthritis | 1 | 1977 | 684 | 0.000 |
Why?
|
| Injections, Jet | 1 | 1971 | 8 | 0.000 |
Why?
|
| Erythema | 1 | 1972 | 261 | 0.000 |
Why?
|
| Blood Group Antigens | 1 | 1972 | 185 | 0.000 |
Why?
|
| Isoantigens | 1 | 1972 | 562 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 1986 | 5892 | 0.000 |
Why?
|
| Influenza Vaccines | 1 | 1972 | 780 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1979 | 7860 | 0.000 |
Why?
|